首页> 外文期刊>Japanese journal of radiology >Percutaneous fluoroscopically guided n-butyl cyanoacrylate (NBCA) injection for iatrogenic femoral arterial pseudoaneurysm under temporary balloon occlusion of arterial blood flow.
【24h】

Percutaneous fluoroscopically guided n-butyl cyanoacrylate (NBCA) injection for iatrogenic femoral arterial pseudoaneurysm under temporary balloon occlusion of arterial blood flow.

机译:经皮透视引导下的氰基丙烯酸正丁酯(NBCA)注射用于暂时性球囊阻塞性动脉血流的医源性股动脉假性动脉瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

To evaluate the safety and efficacy of n-butyl cyanoacrylate (NBCA) injection under fluoroscopy for iatrogenic femoral artery pseudoaneurysms under temporary balloon occlusion.This treatment was approved by the Ethics Committee of our institute, and informed consent was obtained from the patients. Three male patients aged 82, 77, and 51?years developed femoral arterial pseudoaneurysms after catheterization. The pseudoaneurysms (diameter: 30, 12, and 15?mm; neck diameter: 1.8, 5.2, and 1.4?mm) were treated with percutaneous NBCA injection under fluoroscopy after failed ultrasound (US)-guided compression. First, a 4-Fr balloon catheter was inserted into the responsible femoral artery via the contralateral approach. An 18-gauge needle was placed in the pseudoaneurysm under US guidance, and a test injection of contrast medium was performed under fluoroscopic guidance to evaluate the extent of the pseudoaneurysm. NBCA-lipiodol (Lp) (ratio, 1:3) was then injected under balloon inflation. The balloon catheter was deflated and withdrawn after treatment.The total volume of the injected NBCA-Lp was 0.4-1.5?ml. In each case, angiography immediately after NBCA-Lp injection showed eradication of the pseudoaneurysm, and color Doppler US revealed no blood flow signal. No complications were observed. Color Doppler US showed no recurrence in the three patients at their last follow-ups at 6, 12, and 12?months.Percutaneous NBCA injection under fluoroscopy with the support of balloon inflation was safe, feasible, and useful for eradicating iatrogenic femoral artery pseudoaneurysms in three cases following failed US compression.
机译:为评估荧光球镜下注射氰基丙烯酸正丁酯(NBCA)在暂时性球囊闭塞下医源性股动脉假性动脉瘤的安全性和有效性,该治疗方法已获得本院伦理委员会的批准,并获得患者的知情同意。三名年龄分别为82、77和51岁的男性患者在导管插入后出现股动脉假性动脉瘤。超声(US)引导的压缩失败后,在荧光检查下经皮NBCA注射治疗假性动脉瘤(直径:30、12和15?mm;颈部直径:1.8、5.2和1.4?mm)。首先,通过对侧入路将4-Fr球囊导管插入股动脉。在US引导下将18号针头置于假性动脉瘤中,并在荧光镜引导下进行对比剂的测试注射以评估假性动脉瘤的程度。然后在气囊充气下注射NBCA-碘油(Lp)(比例为1:3)。处理后将球囊导管放气并抽出。注射的NBCA-Lp的总体积为0.4-1.5?ml。在每种情况下,NBCA-Lp注射后立即进行的血管造影均显示假性动脉瘤已根除,而彩色多普勒超声未显示血流信号。没有观察到并发症。彩色多普勒超声检查显示3例患者的最后一次随访分别在6、12和12个月没有复发。荧光检查下经皮NBCA注射在球囊充气的支持下是安全,可行的,可用于根除医源性股动脉假性动脉瘤美国压缩失败后的三种情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号